Comparative study of Sugammadex versus neostigmine reversal of moderate rocuronium-induced neuromuscular blockade

Comparative study of Sugammadex versus neostigmine reversal of moderate rocuronium-induced neuromuscular blockade in patients undergoing bronchoscopic lung biopsy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201510001292136

Enrollment

Registered

2015-10-03

Start date

2015-10-15

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory lung biopsy

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ASA III&IV adult patients over 60 years undergo bronchoscopic lung biopsy

Exclusion criteria

Exclusion criteria: a difficult airway known or suspected neuromuscular disorders significant renal dysfunction patients receiving medication likely to interfere with rocuronium

Design outcomes

Primary

Measure	Time frame
is to measure the time to reach train-of-four > 0.9	—

Secondary

Measure	Time frame
blood gas analysis ;peak expiratory flow rate ;Symptoms of pulmonary complications	—

Countries

Egypt

Contacts

Public Contactshahira;shahira el metainy;el metainy

Department of Assistant Professor Anaesthesia and Surgical Intensive Care; Assistant Professor Anaesthesia and Surgical Intensive Care

shelmetainy@yahoo.com;shelmetainy@yahoo.com+01223527804;+01223527804

Outcome results